NCT06356701View on ClinicalTrials.gov

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

PHASE1RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Long-Term Effects Secondary to Cancer Therapy
Interventions
DIETARY_SUPPLEMENT

Cancer nutritional treatment regimen (Spirulina Bifidobacterium Capsules, Fish Oil Grape Seed Blueberry Soft Capsules, Ganoderma Spore Oil Soft Capsules)

"Medication for Research :~* Spirulina Bifidobacterium Capsules~* Fish Oil Grape Seed Blueberry Soft Capsules;~* Ganoderma Lucidum Sporoderm Oil Soft Capsules; oral administration. non-squamous cell carcinoma Drug: Pemetrexed+Cisplatin (or carboplatin)~ * Sintilimab Injection/Camrelizumab/Tislelizumab/Atezolizumab Injection IV infusion squamous cell carcinoma Drug:Paclitaxel+ Cisplatin (or carboplatin)~ * Sintilimab Injection/Camrelizumab/Tislelizumab/Atezolizumab Injection IV infusion"

Trial Locations (1)

116000

RECRUITING

DongYan, Dalian

All Listed Sponsors
lead

The First Affiliated Hospital of Dalian Medical University

OTHER